The challenge of the obesity epidemic is widespread and one that even pediatricians face constantly,” a Connecticut doctor said.

The prospects of a new class of Duchenne muscular dystrophy therapies have taken another downturn after Roche abandoned development of RG6206, a myostatin inhibitor. The Swiss group revealed the ...

A few years later, a clinical trial of a myostatin inhibitor called stamulumab (MYO-029) developed by Wyeth (which was acquired by Pfizer in 2009) showed some promise in early trials but was ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

The UConn team’s research has already shown in the lab in mouse models that myostatin inhibitors cause fat loss, so they are currently examining the possibility of developing them as future ...

TYK2/JAK1 inhibition for neuroinflammatory disorders; glutamate modulation for OCD and SCA; myostatin inhibition for neuromuscular and metabolic diseases, including SMA and obesity; antibody ...